Adam Washburn is a Director and Lab Automation Lead at Eli Lilly and Company, where he leads efforts to modernize and transform analytical laboratory operations through advanced automation and digital integration. In this role, he works at the intersection of analytical science, engineering, and information technology to develop scalable solutions that improve laboratory efficiency, data integrity, and scientific productivity across Lilly's biopharmaceutical development portfolio. With a background spanning analytical development, laboratory systems, and scientific automation, Adam has contributed to multiple therapeutic programs while helping organizations adopt innovative technologies that streamline complex laboratory processes.
For conference production and speaking opportunites:
For sponsorship and exhibition opportunities: